Cutaneous Lymphoma — Trials

Cutaneous Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 69
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Mayo Clinic
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05728879	Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011® (RLF-TD011®) Spray Solution	not yet recruiting	Early Phase 1	30	Northwestern UniversityOTHER	1	May 1, 2026	clinicaltrials
NCT05838599	Combining Topical Imiquimod With Local Radiotherapy for Treatment of Mycosis Fungoides	recruiting	Early Phase 1	25	Northwestern UniversityOTHER	1	May 1, 2026	clinicaltrials